In This Section


The evolution of FDA regulatory science and its impact on cancer

Tuesday, June 27, 2023


register for on demand viewing

This is an important time for regulatory science in cancer research. The increasing number and diversity of medical interventions, data opportunities, and novel clinical trial designs are challenging traditional regulatory processes and spurring the need for significant innovation in regulatory practice. Patient expectations for earlier access to innovations and for involvement in regulatory decision-making add to the opportunities for new methodologies and data sources. This AACR Patient Advocate Forum will explore how regulatory science is evolving to meet the growing complexity of cancer research and optimize regulation to support the prevention, diagnosis, and treatment of cancers.


Anna D. Barker, PhD, FAACR, Ellison Institute for Transformative Medicine


Allison Rosen, MS, Project ECHO, American Cancer Society

Richard Pazdur, MD, FDA Oncology Center of Excellence

David R. Parkinson, MD, ESSA Pharma, Inc.

Kenneth C. Anderson, MD, FAACR, Dana-Farber Cancer Institute

Program Agenda Speaker Bios

AACR Patient Advocate Forums

The AACR is committed to providing educational programming to patients with cancer and patient advocacy communities to support their collective mission to find cures for all cancers. AACR Patient Advocate Forums invite leaders from patient advocacy, academia, industry, and healthcare communities to discuss pressing topics and the latest discoveries in cancer research. These virtual forums are provided quarterly at no cost to attendees and open to the public. 

Special thanks to our supporters

Bristol Myers Squibb Daiichi-Sankyo Genmab